S100A12 could promote inflammation and cell apoptosis in sepsis-induced ARDS while inhibiting fibroblast migration via the receptor for advanced glycation end products (Tanaka et al., 2019; Zhang et al., 2020). The gene discussed is S100A12; the disease is Sepsis.